On, Jan. 11, 2022, Tenet Healthcare (THC) filed a Results of Operations and Financial Condition Form 8-K report with the U.S. Securities and Exchange Commission (SEC). The filing hinted at positive news regarding the Texas-based healthcare provider’s Adjusted EBITDA.
During after-hours trading yesterday, Jan. 10, THC stock dropped 0.01%, down to $74.54 per share.
J.P. Morgan Healthcare Conference
Tenet Healthcare Corporation will be giving a slide presentation of materials at the virtual J.P. Morgan Healthcare Conference on January 11, 2022 (3:00 pm EST). Presentation materials should be made available for investors at: www.tenethealth.com/investors
Adjusted EBITDA Announcement
The firm plans to disclosure that it now anticipates that its “Adjusted EBITDA, excluding any fourth quarter stimulus grant income related to the pandemic, will meet or exceed the current Wall Street consensus estimate, as published by FactSet, of its Adjusted EBITDA for the year ended December 31, 2021 of approximately $3.301 billion.” One caveat to pay attention to is the fact that Tenet Healthcare’s financial statement close process has not yet been fully completed.
THC has a Short-Term Technical Rank of 97. Find out what this means to you and get the rest of the rankings on THC!
Tenet Healthcare is a Dallas-based healthcare provider organization operating a collection of hospitals (60 as of September 2021) and over 550 outpatient facilities, including ambulatory surgery centers, urgent care centers, freestanding imaging centers, freestanding emergency rooms/micro-hospitals, and physician practices across the United States. Tenet enjoys the number-one ambulatory surgical center position nationwide, as well.